NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/30/20
Novocure Reports Second Quarter 2020 Financial Results and Provides Company UpdateBusiness Wire • 07/30/20
Missed Out On Rally Of These 5 Healthcare & Software Stocks? There May Still Be TimeForbes • 07/29/20
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research ProgramBusiness Wire • 07/28/20
First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer ArraysBusiness Wire • 07/22/20
Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung CancerBusiness Wire • 07/15/20
NovoCure Limited (NVCR) CEO Asaf Danziger on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/30/20
Here’s Why Growth Of Novocure’s Brain Cancer Treatment Is Only Just StartingThe Motley Fool • 04/22/20
NovoCure Limited (NVCR) CEO Asaf Danziger on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/27/20